Russia, India in vaccine deal
Nov 29, 2020
1 minute
THE Russian Direct Investment Fund (RDIF) and Hetero, one of India’s generic pharmaceutical companies, have agreed to produce in India more than 100 million doses a year of the Sputnik
You’re reading a preview, subscribe to read more.
Start your free 30 days